PCM
IDXX icon

Penserra Capital Management’s Idexx Laboratories IDXX Stock Holding History

Penserra Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3K Hold
6
– – ﹤0.01% 1001
2026
Q1 		$3K Hold
6
– – ﹤0.01% 972
2025
Q4 		$4K Sell
6
-552
-99% -$376K ﹤0.01% 923
2025
Q3 		$355K Buy
558
+552
+9,200% +$335K ﹤0.01% 623
2025
Q2 		$3K Hold
6
– – ﹤0.01% 913
2025
Q1 		$2K Sell
6
-207
-97% -$89.9K ﹤0.01% 980
2024
Q4 		$87K Buy
213
+207
+3,450% +$90.8K ﹤0.01% 872
2024
Q3 		$3K Hold
6
– – ﹤0.01% 981
2024
Q2 		$3K Hold
6
– – ﹤0.01% 1121
2024
Q1 		$3K Sell
6
-819
-99% -$448K ﹤0.01% 1103
2023
Q4 		$457K Buy
825
+360
+77% +$169K 0.01% 549
2023
Q3 		$202K Sell
465
-75
-14% -$37.4K ﹤0.01% 744
2023
Q2 		$271K Sell
540
-4,456
-89% -$2.14M 0.01% 694
2023
Q1 		$2.5M Buy
4,996
+4,992
+124,800% +$2.39M 0.05% 291
2022
Q4 		$1K Buy
+4
New +$1.55K ﹤0.01% 1096
2021
Q3 		– Sell
-530
Closed -$334K – 1487
2021
Q2 		$334K Buy
+530
New +$293K 0.01% 554
2020
Q2 		– Sell
-110
Closed -$31K – 857
2020
Q1 		$31K Sell
110
-5,812
-98% -$1.52M ﹤0.01% 721
2019
Q4 		$1.54M Buy
+5,922
New +$1.56M 0.1% 223
2018
Q3 		– Sell
-7,764
Closed -$1.69M – 717
2018
Q2 		$1.69M Buy
+7,764
New +$1.6M 0.11% 158
2017
Q3 		– Sell
-7,717
Closed -$1.25M – 561
2017
Q2 		$1.25M Buy
7,717
+2,755
+56% +$447K 0.45% 69
2017
Q1 		$767K Buy
+4,962
New +$684K 0.08% 91
2016
Q1 		– Sell
-82
Closed -$6K – 1007
2015
Q4 		$6K Buy
+82
New +$5.85K ﹤0.01% 713

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Penserra Capital Management's IDXX Position: Q2 2026 in Review

Penserra Capital Management held its Idexx Laboratories (IDXX) position steady in Q2 2026 at 6 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #1001.

Penserra Capital Management first reported a position in IDXX in Q4 2015 and has held it in 22 quarters since. The position peaked at $2.5M in Q1 2023. 1,300 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Penserra Capital Management held 6 shares of Idexx Laboratories worth $3K as of Q2 2026.
  • Penserra Capital Management left its Idexx Laboratories share count unchanged in Q2 2026.
  • Idexx Laboratories made up ﹤0.01% of Penserra Capital Management's portfolio in Q2 2026, its #1001 holding.
  • Penserra Capital Management first reported a position in Idexx Laboratories in Q4 2015 and has held it in 22 quarters since.
  • Penserra Capital Management's Idexx Laboratories position peaked at $2.5M in Q1 2023.
  • 1,300 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Penserra Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.